Changeflow GovPing Pharma & Drug Safety USPTO Patent Granted for Oral Whitening Composi...
Routine Rule Added Final

USPTO Patent Granted for Oral Whitening Compositions

Favicon for changeflow.com ChangeBridge: Patent Grants - Pharma (A61K)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted a patent (US12582585B2) to Colgate-Palmolive Company for oral whitening compositions containing potassium peroxymonosulfate with improved stability. The patent covers specific formulations and methods of use for these dental care products.

What changed

The United States Patent and Trademark Office (USPTO) has issued patent US12582585B2 to Colgate-Palmolive Company for "Peroxymonosulfate oral whitening compositions." This patent specifically covers formulations designed for tooth whitening that utilize potassium peroxymonosulfate and exhibit enhanced stability. The grant includes 20 claims related to the composition and its methods of use, with a filing date of December 23, 2022.

This patent grant signifies the protection of intellectual property for Colgate-Palmolive's innovation in oral care. While this is a patent grant and not a regulatory rule imposing direct compliance obligations on other entities, it establishes exclusive rights for the assignee. Companies operating in the oral care or pharmaceutical manufacturing sectors, particularly those developing whitening products, should be aware of this patent to avoid potential infringement and to inform their own product development strategies.

Source document (simplified)

← USPTO Patent Grants

Peroxymonosulfate oral whitening compositions

Grant US12582585B2 Kind: B2 Mar 24, 2026

Assignee

Colgate-Palmolive Company

Inventors

Jonghun Lee, Cajetan Dogo-Isonagie

Abstract

The present disclosure provides tooth whitening oral care compositions comprising potassium peroxymonosulfate having improved stability, and methods of using the same.

CPC Classifications

A61Q 11/00 A61K 8/00

Filing Date

2022-12-23

Application No.

18088446

Claims

20

View original document →

Named provisions

Peroxymonosulfate oral whitening compositions

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12582585B2

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Product Development Intellectual Property
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Product Development Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.